Mr. Michael A. Trinkle

The names of the nominees are H. M. Busby; Scott L. Glenn; Eric B. Freedus, Ellen Preston; Michael Trinkle, Michael Walsh and Edward Steube.
...
Michael Trinkle
...
Michael A. Trinkle currently serves as President of Conception Technologies, LP, and has held the position since 1993.Mr. Trinkle was also a member of Allergy Free, LLC, and served as its President from August 2001 to March 31, 2004.During the 15 years prior to joining Conception Technologies, LP, Mr. Trinkle was employed by Allergan Pharmaceuticals where he held management positions in the areas of operations, sales, marketing, and quality assurance.Mr. Trinkle was elected to the Board in November 2004.
...
The Audit Committee is comprised of Mike Trinkle and H. M. Busby.
...
The current members of the Committee are Michael Trinkle and Scott Glenn.
...
Mr. Trinkle may not be considered an independent director because Mr. Trinkle is the president of Conception Technologies, an affiliate of Mr. Glenn.

0001309532 Trinkle Michael 3495 VIA ZARA COURT FALLBROOK CA 92028 1 0 0 0

The names of the nominees are H. M. Busby; Scott L. Glenn; Eric B. Freedus, Ellen Preston; Michael Trinkle, Michael Walsh and Edward Steube.
...
Michael Trinkle
...
Michael A. Trinkle currently serves as President of Conception Technologies, LP, a medical device company focused on reproductive medicine, and has held the position since 1993.Mr. Trinkle was also a member of Allergy Free, LLC, and served as its President from August 2001 to March 31, 2004.During the 15 years prior to joining Conception Technologies, LP, Mr. Trinkle was employed by Allergan Pharmaceuticals where he held management positions in the areas of operations, sales, marketing, and quality assurance.Mr. Trinkle was elected to the Board in November 2004.
...
The Audit Committee is comprised of Mike Trinkle and H.M. Busby.
...
Mr. Trinkle and Mr. Busby may not be considered independent directors because Mr. Trinkle is the president of Conception Technologies, an affiliate of Mr. Glenn, and Mr. Busby is the former CEO of Planet.
...
Mr. Trinkle and Mr. Busby may not be considered independent directors because Mr. Trinkle is the president of Conception Technologies, an affiliate of Mr. Glenn, and Mr. Busby is the former CEO of Planet.
...
The current members of the Committee are Michael Trinkle and Scott Glenn.
...
Mr. Trinkle may not be considered an independent director because Mr. Trinkle is the president of Conception Technologies, an affiliate of Mr. Glenn.

The names of the nominees are H. M. Busby; Scott L. Glenn; Eric B. Freedus, Ellen Preston; and Michael Trinkle.
...
Michael Trinkle
...
Michael A. Trinkle currently serves as President of Conception Technologies, LP, a medical device company focused on reproductive medicine, and has held the position since 1993.Mr. Trinkle was also a member of Allergy Free, LLC, and served as its President from August 2001 to March 31, 2004.During the 15 years prior to joining Conception Technologies, LP, Mr. Trinkle was employed by Allergan Pharmaceuticals where he held management positions in the areas of operations, sales, marketing, and quality assurance.Mr. Trinkle was elected to the Board in November 2004.
...
In addition, in 2004 the Company's entire current Board acted as the Nominating Committee and nominated Scott Glenn, Michael Trinkle and Ellen Preston to serve as directors with Robert Petcavich and H. Mac Busby in compliance with the Agreement and Plan of Merger dated March 18, 2004, and entered into by and between the Company and Allergy Free, LLC.
...
On November 17, 2004, Michael Trinkle and H. Mac Busby were approved as Audit Committee members.
...
On November 17, 2004, Scott Glenn and Michael Trinkle were approved as Nominating Committee members The Nominating Committee will be responsible for identifying, evaluating, and recommending candidates to serve as directors of the Company and to serve as a focal point for communication between such candidates, the Board, and the Company's management and will make recommendations to the Board of Directors concerning the nomination of candidates to be elected by the Company's shareholders as a director of the Company.

The names of the nominees are H. M. Busby; Scott L. Glenn; Robert J. Petcavich, Ph. D.; Ellen Preston; and Michael Trinkle.
...
Michael A. Trinkle
...
Michael A. Trinkle currently serves as President of Conception Technologies, LP, and has held the position since 1993.Mr. Trinkle is also a member of Allergy Free, LLC, and served as its President from August 2001 to March 31, 2004.During the 15 years prior to joining Conception Technologies, LP, Mr. Trinkle was employed by Allergan Pharmaceuticals where he held management positions in the areas of operations, sales, marketing, and quality assurance.

The names of the nominees are H. M. Busby; Scott L. Glenn; Robert J. Petcavich, Ph. D.; Ellen Preston; and Michael Trinkle.
...
Michael A. Trinkle
...
Michael A. Trinkle currently serves as President of Conception Technologies, LP, and has held the position since 1993.Mr. Trinkle is also a member of Allergy Free, LLC, and served as its President from August 2001 to March 31, 2004.During the 15 years prior to joining Conception Technologies, LP, Mr. Trinkle was employed by Allergan Pharmaceuticals where he held management positions in the areas of operations, sales, marketing, and quality assurance.

The names of the nominees are Scott L. Glenn; Robert J. Petcavich, Ph. D.; H. M. Busby; Michael Trinkle; and Ellen Preston.
...
Michael A. Trinkle (1) (2)
...
Michael A. Trinkle currently serves as President of Conception Technologies, LP, and has held the position since 1993.Mr. Trinkle is also a member of Allergy Free, LLC, and served as its President from August 2001 to March 31, 2004.During the 15 years prior to joining Conception Technologies, LP, Mr. Trinkle was employed by

At the meeting, the shareholders added Scott L. Glenn, Michael Trinkle and Ellen Preston to the Board along with reelecting current members H. Mac Busby and Robert J. Petcavich to serve as directors of the company until the 2005 annual meeting.
...
Mr. Trinkle has been an executive in the healthcare industry for over 25 years.Currently he is President of Conception Technologies and prior to that was at Allergan Pharmaceuticals, Inc.

Michael Trinkle
...
Michael A. Trinkle currently serves as President of Conception Technologies, LP, and has held the position since 1993.Mr. Trinkle was also a member of Allergy Free, LLC, and served as its President from August 2001 to March 31, 2004.During the 15 years prior to joining Conception Technologies, LP, Mr. Trinkle was employed by Allergan Pharmaceuticals where he held management positions in the areas of operations, sales, marketing, and quality assurance.Mr. Trinkle was elected to the Board in November 2004.
...
The Audit Committee is comprised of Mike Trinkle and H. M. Busby.

Freedus, Ellen Preston; and Michael Trinkle.
...
Michael Trinkle
...
Michael A. Trinkle currently serves as President of Conception Technologies, LP, and has held the position since 1993.Mr. Trinkle was also a member of Allergy Free, LLC, and served as its President from August 2001 to March 31, 2004.During the 15 years prior to joining Conception Technologies, LP, Mr. Trinkle was employed by Allergan Pharmaceuticals where he held management positions in the areas of operations, sales, marketing, and quality assurance.Mr. Trinkle was elected to the Board in November 2004.
...
In addition, in 2004 the Company's entire current Board acted as the Nominating Committee and nominated Scott Glenn, Michael Trinkle and Ellen Preston to serve as directors with Robert Petcavich and H. Mac Busby in compliance with the Asset Purchase Agreement dated March 18, 2004, and entered into by and between the Company and Allergy Free, LLC.
...
On November 17, 2004, Michael Trinkle and H. Mac Busby were approved as Audit Committee members.
...
On November 17, 2004, Scott Glenn and Michael Trinkle were approved as Nominating Committee members The Nominating Committee will be responsible for identifying, evaluating, and recommending candidates to serve as directors of the Company and to serve as a focal point for communication between such candidates, the Board, and the Company's management and will make recommendations to the Board of Directors concerning the nomination of candidates to be elected by the Company's shareholders as a director of the Company.